Dai L - Search Results

1

Breast cancer is associated with coronary heart disease: a cross-sectional survey of NHANES 1999-2018.

Dai L, Li R, Hao Q, Bao Y, Hu L, Zhang Y, Kang H, Wu H, Ma X, Song Y. Dai L, et al. Front Cardiovasc Med. 2023 Dec 6;10:1274976. doi: 10.3389/fcvm.2023.1274976. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 38124895 Free PMC article.

2

Nomogram Predicts the Role of Primary Tumor Surgery on De Novo Stage-IV Breast Cancer Patients: A SEER-Based Competing Risk Analysis Model.

Cui H, Dai L, Bao Y, Hu L, Zhou Z, Wang M, Lin S, Wu H, Ma X, Kang H. Cui H, et al. Among authors: dai l. Front Oncol. 2022 May 4;12:819531. doi: 10.3389/fonc.2022.819531. eCollection 2022. Front Oncol. 2022. PMID: 35600374 Free PMC article.

3

The relationship between immediate postmastectomy reconstruction modalities and survival benefits in patients with triple negative breast cancer.

Dai L, Cui H, Bao Y, Hu L, Zhou Z, Wang M, Lin S, Wu H, Kang H, Ma X. Dai L, et al. Cancer Med. 2023 Feb;12(3):2782-2794. doi: 10.1002/cam4.5166. Epub 2022 Sep 15. Cancer Med. 2023. PMID: 36106621 Free PMC article.

4

Identification of glycogene signature as a tool to predict the clinical outcome and immunotherapy response in breast cancer.

Lin S, Tan Z, Cui H, Ma Q, Zhao X, Wu J, Dai L, Kang H, Guan F, Dai Z. Lin S, et al. Among authors: dai l, dai z. Front Oncol. 2022 Sep 14;12:854284. doi: 10.3389/fonc.2022.854284. eCollection 2022. Front Oncol. 2022. PMID: 36185271 Free PMC article.

5

Prognostic effect of radiotherapy in breast cancer patients underwent immediate reconstruction after mastectomy.

Dai L, Cui H, Bao Y, Hu L, Zhou Z, Lin S, Zhang X, Wu H, Kang H, Ma X. Dai L, et al. Front Oncol. 2022 Nov 2;12:1010088. doi: 10.3389/fonc.2022.1010088. eCollection 2022. Front Oncol. 2022. PMID: 36408183 Free PMC article.

6

Low-density lipoprotein: a versatile nanoscale platform for targeted delivery.

Dai L, Li S, Hao Q, Zhou R, Zhou H, Lei W, Kang H, Wu H, Li Y, Ma X. Dai L, et al. Nanoscale Adv. 2023 Jan 24;5(4):1011-1022. doi: 10.1039/d2na00883a. eCollection 2023 Feb 14. Nanoscale Adv. 2023. PMID: 36798503 Free PMC article. Review.

7

Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer.

Cui H, Ren X, Dai L, Chang L, Liu D, Zhai Z, Kang H, Ma X. Cui H, et al. Among authors: dai l. Front Immunol. 2023 Mar 8;14:1145552. doi: 10.3389/fimmu.2023.1145552. eCollection 2023. Front Immunol. 2023. PMID: 36969219 Free PMC article.

8

Prognostic value and mode selection of locoregional treatment in Stage-IV breast cancer patients.

Cui H, Ren X, Zhao X, Dai L, Liu D, Bao Y, Hu L, Xiao Z, Ma X, Kang H. Cui H, et al. Among authors: dai l. J Cancer Res Clin Oncol. 2023 Nov;149(15):13591-13605. doi: 10.1007/s00432-023-05159-2. Epub 2023 Jul 29. J Cancer Res Clin Oncol. 2023. PMID: 37515611

9

Effect of T Stages on the Choice of Axillary Evaluation Modality in Breast Cancer Patients With 1-2 Sentinel Lymph Node Metastases.

Liu D, Chang L, Zhao X, Dai L, Cui H, Liu P, Zhai Z, Wu H, Ma X, Kang H. Liu D, et al. Among authors: dai l. Clin Breast Cancer. 2024 Jun;24(4):e232-e243.e1. doi: 10.1016/j.clbc.2024.01.012. Epub 2024 Jan 24. Clin Breast Cancer. 2024. PMID: 38368246

10

PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer.

Ren X, Cui H, Dai L, Chang L, Liu D, Yan W, Zhao X, Kang H, Ma X. Ren X, et al. Among authors: dai l. J Cancer Res Clin Oncol. 2024 Mar 11;150(3):119. doi: 10.1007/s00432-024-05626-4. J Cancer Res Clin Oncol. 2024. PMID: 38466449 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,505 results

Search Page

Filters